Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex’ Late Stage Innovative Treatment for Multiple Oncology Indications (Press release issued by Teva)
PhRMA Deal Intact As Senate Health Reform Bill Enters Home Stretch (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Crestor Advisory Meeting Weighs Value Of C-Reactive Protein Risk Marker (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
CPEX Pharmaceuticals completes enrollment in Nasulin Phase 2a clinical trial (Medical News.Net)
Eli Lilly, Incyte sign drug development deal (The Associated Press)
NexMed stays on Nasdaq after Bio-Quant buy (Outsourcing Pharma.com)
BI’s Spiriva HandiHaler Joins GSK’s Advair Diskus In COPD Exacerbations Reduction Claim (The Pink Sheet)
CPEX Pharmaceuticals Announces Completion of Enrollment in Phase 2a Clinical Trial of Nasulin(TM) (Trading Markets)
Pfizer Acquires a Stem-Cell Therapy (The New York Times)
Sanofi-aventis to Acquire Chattem Inc. (Press release issued by Sanofi-aventis)
Human Genome (HGSI) Shares Rising as Morgan Stanley Starts at Overweight (StreetInsider.com)
Merck to buy Avecia Biologics (BioSpectrum)
SUBSCRIBE